Havas

By Rob Dhoble, Managing Director at Havas ECS. What if physicians in all 50 states consistently understood the endocannabinoid system (ECS), and the extensive clinical data supporting use of medical cannabis, prescription cannabinoids, and hemp-derived non-prescription cannabinoids? Would each US...

Earlier this month, the French multinational advertising and public relations giant Havas announced the release of its cannabis division: Havas ECS. The company, which is majority-owned by Vivendi SA (OTC: VIVEF) (OTC: VIVHY), announced it would open offices in New York and New Jersey...

The international advertising and public relations company Havas Group, which is majority-owned by Vivendi SA (OTC: VIVEF) (OTC: VIVHY), has launched a cannabis consultancy firm: Havas ECS. What Happened The multi-office venture aims to become a “specialized strategic communications...